Bausch + Lomb IPO Will Open Tap Further For Paying Down Bausch Health Debt

Paying down Bausch Health’s debt, incurred during previous management’s expansion-by-acquisition strategy when the firm operated as Valeant, has been a box to check from the start of preparing to separate Bausch + Lomb, says CEO Joseph Papa.

• Source: Alamy

Bausch Health Companies Inc.’s planned spin-out of Bausch + Lomb Inc. not only turns loose a portfolio of vision care products from surgical technologies to OTC drugs and dietary supplements, but also further opens a tap for paying down its debt.

Paying down Bausch Health’s debt, largely incurred during the previous management’s ill-advised expansion-by-acquisition strategy when the firm operated as Valeant...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from Business

More from Wellness